EFSA:Safety of water extract of Cistanche tubulosa stems as a Novel food pursuant to Regulation (EU) 2015/2283
Jan 31, 2021
The Panel notes that an integrated analysis of three studies covering 1,076 patients with vascular dementia treated with the proposed NF at a daily dose of 1,800 mg, reported that 12 adverse events (AEs) were classified to be âdefinitelyâ, âprobablyâ or âpossibly relatedâ to the exposure to the NF. Two of these AE were classified as severe (cerebral haemorrhage and epilepsy). The Panel considers that the reported AEs raise safety concerns.
For further information (in English), click on the Link
Tags:
EU - Healthier Food Choices: From Consumer Information to Consumer Empowerment in EU Law
European Union
Apr 17, 2024
BFSA publishes draft Food Safety (Sample Collection, Testing, and Analysis) Regulations
Bangladesh
Apr 15, 2024
MFDS added 4 new ingredients prohibited from imported foods
South Korea
Apr 15, 2024
FDA Report on Economically Motivated Adulteration in Honey
USA
Apr 12, 2024
Moringa Oleifera under review as a new food in Australia and New Zealand
Australia
Apr 12, 2024
Commission authorizes beta-glucan from Euglena gracilis as a novel food
European Union
Apr 11, 2024
Commission authorizes calcidiol monohydrate as a novel food
European Union
Apr 11, 2024
FDA warns about toxic yellow oleander in dietary supplements
USA
Apr 11, 2024
New max levels for T-2 and HT-2 toxins in food and grains
European Union
Apr 11, 2024
Bangladesh strengthens food recall systems
Bangladesh
Apr 11, 2024
Commission authorizes monosodium salt of L-5-methyltetrahydrofolic acid as a novel food
European Union
Apr 11, 2024
Commission authorizes 3′-Sialyllactose sodium salt as a novel food
European Union
Apr 11, 2024
Commission authorizes Duckweed protein as a novel food
European Union
Apr 11, 2024
The EU provides a more informed breakfast
European Union
Apr 11, 2024
Amendment to maximum levels of DON in food
European Union
Apr 10, 2024